| Ms Rebecca Dee Chapman, OTRL | |
|
700 Randolph St, Radford, VA 24141-2430 | |
| (540) 633-3708 | |
| Not Available |
| Full Name | Ms Rebecca Dee Chapman |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 700 Randolph St, Radford, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013354695 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119005963 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rebecca Dee Chapman, OTRL 121 High St, Dublin, VA 24084-3338 Ph: (540) 641-3842 | Ms Rebecca Dee Chapman, OTRL 700 Randolph St, Radford, VA 24141-2430 Ph: (540) 633-3708 |
News Archive
Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant factor VIII product indicated for both the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A.
Jay Keasling, a leading authority and pioneer on synthetic biology who has engineered microbial "factories" to manufacture an affordable version of a frontline antimalarial drug and biofuel substitutes for gasoline, diesel and jet fuel, has won a 2012 Heinz Award, which is presented by the Heinz Family Foundation and carries with it a cash prize of $250,000.
Volume V, Issue 2 of the online journal Global Health Governance is now available online. Among other articles, the issue features a piece examining the sustainability of sub-regional disease surveillance networks, a piece examining the impact of regional health meetings in the Pacific on health governance, and a commentary on investing in strengthening health systems.
A number of drugs already approved to treat parasitic infections, cancers, infertility and other conditions also show promise as antibiotic agents against staph and tuberculosis infections, according to a new study by University of Illinois chemists and collaborators. Because these agents act against multiple targets within the bacteria, it may be harder for bacteria to develop resistance.
Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need.
› Verified 4 days ago
Kody A Stewart, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 307 Clement St, Radford, VA 24141 Phone: 330-727-8484 | |
Ashley Fertall, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Randolph St, Radford, VA 24141 Phone: 540-633-3708 | |
Cynthia Beth Kurz, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Randolph St, Radford, VA 24141 Phone: 540-633-3708 | |
Lambros Dallas, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 E Main St, Radford, VA 24142 Phone: 540-831-2693 | |
Mr. Daniel G Jaasma, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Randolph St, Radford, VA 24141 Phone: 540-633-6533 | |
Mrs. Margaret Bola Kolajo, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Randolph St, Radford, VA 24141 Phone: 540-633-6533 |